Effect of diet-induced obesity or type 1 or type 2 diabetes on corneal nerves and peripheral neuropathy in C57Bl/6J mice

Journal of the Peripheral Nervous System

Volumn 20, Issue 1, 2015, Pages 24-31

  Yorek, Matthew S ^a,b   Obrosov, Alexander ^c   Shevalye, Hanna ^c   Holmes, Amey ^a   Harper, Matthew M ^a,b,c   Kardon, Randy H ^a,b,c   Yorek, Mark A ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VA Center of Excellence for Prevention and Treatment of Visual Loss   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

corneal confocal microscopy; corneal nerves; diabetes; diabetic peripheral neuropathy; obesity

Indexed keywords

HEMOGLOBIN A1C; 3-NITROTYROSINE; 4-HYDROXY-2-NONENAL; ALDEHYDE; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEAL NERVE; DISEASE ASSOCIATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MECHANICAL STIMULATION; MOUSE; NERVE; NERVE CONDUCTION; NEUROANATOMY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SKIN NERVE; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CORNEA; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHY; DIET; GLUCOSE TOLERANCE TEST; INNERVATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPINAL GANGLION;

ALDEHYDES; ANIMALS; CORNEA; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DIET; GANGLIA, SPINAL; GLUCOSE TOLERANCE TEST; MICE; MICE, INBRED C57BL; NEURAL CONDUCTION; OBESITY; TYROSINE;

EID: 84930977724     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/jns.12111     Document Type: Article

References (36)

1. Asghar O, Petropoulos I, Alam U, Jones W, Jeziorska M, Marshall A, Ponirakis G, Fadavi H, Boulton A, Tavakoli M, Malik R, (2014). Corneal confocal microscopy detects neuropathy in subjects with impaired glucose tolerance. Diabetes Care 37: 2643-2646.
2. Bansal P, Paul P, Mudgal J, Nayak P, Pannakae S, Priyadarsini K, Unnikrishnan M, (2012). Antidiabetic, antihyperlipidemic and antioxidant effects of the flavonoid rich fraction of Pilea microphylla (L.) in high fat diet/streptozotocin-induced diabetes in mice. Exp Toxicol Pathol 64: 651-658.
3. Calcutt N, Jolivalt C, Fernyhough P, (2008). Growth factors as therapeutics for diabetic neuropathy. Curr Drug Targets 9: 47-59.
4. Chen D, Frizzi K, Guernsey L, Ladt K, Mizisin A, Calcutt N, (2013). Repeated monitoring of corneal nerves by confocal microscopy as an index of peripheral neuropathy in type-1 diabetic rodents and the effects of topical insulin. J Peripher Nerv Syst 18: 306-315.
5. Coppey L, Davidson E, Lu B, Gerard C, Yorek M, (2011). Vasopeptidase inhibitor ilepatril (AVE7688) prevents obesity- and diabetes-induced neuropathy in C57Bl/6J mice. Neuropharmacology 60: 259-266.
6. Davidson E, Coppey L, Holmes A, Dake B, Yorek M, (2011). Effect of treatment of high fat/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications. Eur J Pharmacol 668: 497-506.
7. Davidson E, Coppey L, Holmes A, Yorek M, (2012). Changes in corneal innervation and sensitivity and acetylcholine-mediated vascular relaxation of the posterior ciliary artery in a type 2 diabetic rat. Invest Ophthalmol Vis Sci 53: 1182-1187.
8. Davidson E, Coppey L, Kardon R, Yorek M, (2014). Differences and similarities in development of corneal nerve damage and peripheral neuropathy and in diet-induced obesity and type 2 diabetic rats. Invest Ophthalmol Vis Sci 55: 1222-1230.
9. Davis J, Cain J, Banz W, Peterson R, (2013). Age-related differences in response to high-fat feeding on adipose tissue and metabolic profile in ZDSD rats. ISRN Obes 2013: 584547.
10. Divisova S, Vickova E, Hnojcikova M, Skorna M, Nemec M, Dubovy P, Dusek L, Larkovsky J, Belobradkova J, Bednarik J, (2012). Prediabetes/early diabetes-associated neuropathy predominantly involves sensory small fibers. J Peripher Nerv Syst 17: 341-350.
11. Fellmann L, Nascimento A, Tibirica E, Bousquet P, (2013). Murine models for pharmacological studies of the metabolic syndrome. Pharmacol Ther 137: 331-340.
12. Fu Y, Luo J, Jia Z, Zhen W, Zhou K, Gilbert E, Liu D, (2014). Baicalein protects against type 2 diabetes via promoting islet β-cell function in obese diabetic mice. Int J Endocrinol 2014: 846742.
13. Hoke A, (2012). Animal models of peripheral neuropathies. Neurotherapeutics 9: 262-269.
14. Islam M, (2013). Animal models of diabetic neuropathy: progress since 1960s. J Diabetes Res 2013: 149452.
15. Kim H, Kim J, Yoon Y, (2012). Emerging therapy for diabetic neuropathy: cell therapy targeting vessels and nerves. Endocr Metab Immune Discord Drug Targets 12: 168-178.
16. Lenzen S, (2008). The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51: 216-226.
17. Lin Y, Hu G, Li K, Zhao Y, Wei J, Zhen Y, (2014). The protection of Rhein lysinate to liver in diabetic mice induced by high-fat diet and streptozotocin. Arch Pharm Res. DOI: 10.1007/s12272-014-0423-4.
18. Lupachyk S, Watcho P, Shevalye H, Vareniuk I, Obrosov A, Obrosova I, Yorek M, (2013). Na +/H-exchanger-1 inhibition reverses manifestation of peripheral diabetic neuropathy in type 1 diabetic rats. Am J Physiol Endocrinol Metab 305: E396-E404.
19. Lv L, Wu S, Wang G, Zhang J, Pang J, Liu Z, Xu W, Wu S, Rao J, (2010). Effect of astragaloside IV on hepatic glucose-regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin. Phytother Res 24: 219-224.
20. Mahmood D, Singh B, Akhtar M, (2009). Diabetic neuropathy: therapies on the horizon. J Pharm Pharmacol 61: 1137-1145.
21. Mali V, Ning R, Chen J, Yang X, Xu J, Palaniyandi S, (2014). Impairment of aldehyde dehydrogenase-2 by 4-hydroxy-2-nonenal adduct formation and cardiomyocite hypertrophy in mice fed a high-fat diet and injected with low-dose streptozotocin. Exp Biol Med 239: 610-618.
22. Obrosova I, (2003). Update on the pathogenesis of diabetic neuropathy. Curr Diab Rep 3: 439-445.
23. Rees D, Alcolado J, (2005). Animal models of diabetes mellitus. Diabet Med 22: 359-370.
24. Reinwald S, Peterson R, Allen M, Burr D, (2009). Skeletal changes associated with the onset of type 2 diabtes in the ZDF and ZDSD rodent models. Am J Physiol Endocrinol Metab 296: E765-E774.
25. Sakai T, Kusakabe T, Ebihara K, Aotani D, Yamamoto-Kataoka S, Mingming Z, Gumbilai V, Ebihara C, Aizawa-Abe M, Yamamoto Y, Noguchi M, Fujikura J, Hosoda K, Inagaki N, Nakao K, (2014). Leptin restores the insulinotropic effect of exenatide in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and high-fat diet. Am J Physiol Endocrinol Metab 307: E712-E719.
26. Smith A, Russell J, Feldman E, Goldstein J, Peltier A, Smith S, Hamwi J, Pollari D, Bixby B, Howard J, Singleton J, (2006). Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 29: 1294-1299.
27. Stables C, Glasser R, Feldman E, (2013). Diabetic cardiac autonomic neuropathy: insights from animal models. Auton Neurosci 177: 74-80.
28. Stavniichuk R, Shevalye H, Lupachyk S, Obrosov A, Groves J, Obrosova I, Yorek M, (2014). Peroxynitrite and Protein Nitration in the Pathogenesis of Diabetic Peripheral Neuropathy. Diabetes Metab Res Rev 30: 669-678.
29. Tesch G, Lim A, (2011). Recent insights into diabetic renal injury from the db/db mouse model of type 2 diabetic nephropathy. Am J Physiol Renal Physiol 300: F301-F310.
30. Ullevig S, Zhao Q, Zamora D, Asmis R, (2011). Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis. Atherosclerosis 219: 409-416.
31. Wang Z, Hsu C, Lin H, Chen J, (2014). Antidiabetic effects of Carassius autatus complex formula in high fat diet combined streptozotocin-induced diabetic mice. Evid Based Complement Alternat Med 2014: 628473.
32. Weber D, Kneschke N, Grimm S, Bergheim I, Breusing N, Grune T, (2012). Rapid and sensitive determination of protein-nitrotyrosine by ELISA: application to human plasma. Free Radic Res 46: 276-285.
33. Xue J, Ding W, Liu Y, (2010). Anti-diabetic effects of emodin involved in the activation of PPAR gamma on high-fat diet-fed and low dose streptozotocin-induced diabetic mice. Fitoterapia 81: 173-177.
34. Yorek M, (2003). The role of oxidative stress in diabetic vascular and neural disease. Free Radic Res 37: 471-480.
35. Yorek M, Obrosov A, Shevalye H, Lupachyk S, Harper M, Kardon R, Yorek M, (2014). Effect of glycemic control on corneal nerves and peripheral neuropathy in streptozotocin-induced diabetic C57Bl/6J mice. J Peripher Nerv Syst 19: 205-217.
36. Zhu N, Liu B, Luo W, Zhang Y, Li H, Li S, Zhou Y, (2014). Vasoconstrictor role of cyclooxygenase-1-mediated prostacyclin synthesis in non-insulin-dependent diabetic mice induced by high-fat diet and streptozotocin. Am J Physiol Heart Circ Physiol 307: H319-H327.